JPY 160.0
(-0.63%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -1.47 Billion JPY | -395.3% |
2022 | -298 Million JPY | 39.43% |
2021 | -492 Million JPY | -733.9% |
2020 | -59 Million JPY | 61.18% |
2019 | -152 Million JPY | 75.95% |
2018 | -632 Million JPY | 6.09% |
2017 | -673 Million JPY | 14.74% |
2016 | -789.33 Million JPY | -9.93% |
2015 | -718.05 Million JPY | 21.6% |
2014 | -915.89 Million JPY | -33.09% |
2013 | -688.17 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 11 Million JPY | 102.1% |
2023 Q3 | -349 Million JPY | 62.59% |
2023 FY | -1.47 Billion JPY | -395.3% |
2023 Q1 | 330 Million JPY | 190.16% |
2023 Q4 | -525 Million JPY | -50.43% |
2023 Q2 | -933 Million JPY | -382.73% |
2022 FY | -298 Million JPY | 39.43% |
2022 Q3 | -200 Million JPY | -840.74% |
2022 Q4 | -366 Million JPY | -83.0% |
2022 Q2 | 27 Million JPY | -88.93% |
2022 Q1 | 244 Million JPY | 156.84% |
2021 Q4 | 95 Million JPY | 159.75% |
2021 Q2 | -151 Million JPY | 45.29% |
2021 Q3 | -159 Million JPY | -5.3% |
2021 FY | -492 Million JPY | -733.9% |
2021 Q1 | -276 Million JPY | -97.14% |
2020 FY | -59 Million JPY | 61.18% |
2020 Q3 | -86 Million JPY | -129.05% |
2020 Q1 | -129 Million JPY | 7.19% |
2020 Q2 | 296 Million JPY | 329.46% |
2020 Q4 | -140 Million JPY | -62.79% |
2019 Q4 | -139 Million JPY | -240.4% |
2019 Q2 | -268 Million JPY | -271.79% |
2019 Q1 | 156 Million JPY | 136.79% |
2019 FY | -152 Million JPY | 75.95% |
2019 Q3 | 99 Million JPY | 136.94% |
2018 Q2 | -41 Million JPY | 78.97% |
2018 Q3 | 28 Million JPY | 168.29% |
2018 Q4 | -424 Million JPY | -1614.29% |
2018 FY | -632 Million JPY | 6.09% |
2018 Q1 | -195 Million JPY | -11.79% |
2017 Q1 | -258.43 Million JPY | -103.9% |
2017 FY | -673 Million JPY | 14.74% |
2017 Q4 | -174.43 Million JPY | -115.35% |
2017 Q3 | -81 Million JPY | 28.95% |
2017 Q2 | -114 Million JPY | 55.89% |
2016 Q2 | -189.56 Million JPY | 41.68% |
2016 Q4 | -126.74 Million JPY | 14.35% |
2016 Q3 | -147.97 Million JPY | 21.94% |
2016 Q1 | -325.04 Million JPY | -140.21% |
2016 FY | -789.33 Million JPY | -9.93% |
2015 FY | -718.05 Million JPY | 21.6% |
2015 Q4 | -135.31 Million JPY | 30.8% |
2015 Q3 | -195.53 Million JPY | -64.03% |
2015 Q2 | -119.2 Million JPY | 55.52% |
2015 Q1 | -267.99 Million JPY | -36.04% |
2014 Q3 | -344.93 Million JPY | -85.64% |
2014 Q1 | -188.16 Million JPY | 20.77% |
2014 FY | -915.89 Million JPY | -33.09% |
2014 Q4 | -197 Million JPY | 42.89% |
2014 Q2 | -185.8 Million JPY | 1.25% |
2013 FY | -688.17 Million JPY | 0.0% |
2013 Q4 | -237.49 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
DVx Inc. | 172.91 Million JPY | 953.608% |
Seikagaku Corporation | 2.18 Billion JPY | 167.521% |
Eiken Chemical Co., Ltd. | 2.63 Billion JPY | 156.036% |
Create Medic Co., Ltd. | 154.02 Million JPY | 1058.305% |
PHC Holdings Corporation | -12.89 Billion JPY | 88.551% |
Techno Medica Co., Ltd. | 1.34 Billion JPY | 209.485% |
Rion Co., Ltd. | 2.65 Billion JPY | 155.648% |
Nihon Kohden Corporation | 17.02 Billion JPY | 108.669% |
Fukuda Denshi Co., Ltd. | 18.69 Billion JPY | 107.896% |
Japan Lifeline Co., Ltd. | 7.51 Billion JPY | 119.641% |
Japan Medical Dynamic Marketing, INC. | 1.27 Billion JPY | 216.067% |
3-D Matrix, Ltd. | -255.5 Million JPY | -477.679% |